| Table 1. Comparison of clinical parameters between patients undergoing ovarian stimulation with rFSH or hp-hMG. | |||
| rFSH (n=341) | hp-hMG (n=115) | p value | |
|---|---|---|---|
| Age (y) | 35.50 (2.12) | 35.99 (2.13) | 0.034 |
| Weight (kg) | 62.52 (11.37) | 64.64 (14.07) | 0.113 |
| BMI (kg/m2) | 23.34 (3.91) | 23.85 (5.01) | 0.354 |
| Children 0 1 |
338 (99.1) 3 (0.9) |
111 (96.5) 4 (3.5) |
0.071 |
| Basal FSH (mIU/mL) | 8.02 (2.7) | 8.67 (3.80) | 0.059 |
| *TSH (µIU/mL) | 1.99 (1.06) | 1.86 (1.00) | 0.113 |
| *Prolactin (mIU/L) | 271.90 (154.36) | 259.46 (131.15) | 0.573 |
| *AFC (n) | 13.76 (6.08) | 11.84 (6.06) | 0.002 |
Values are presented as mean (standard deviation) or number (%). A p value of < 0.05 was considered significant.
*The p value was calculated after log transformation for normal distribution.
rFSH, recombinant follicle-stimulating hormone; hp-hMG, highly purified-human menopausal gonadotropin; BMI, body mass index; FSH, follicle-stimulating hormone; TSH, thyroid-stimulating hormone; AFC, antral follicle count
Note: Standard reference ranges: FSH: 1-9.2mIU/mL; TSH: 0.5-4.8µIU/mL; Prolactin: 108.78-557.13mIU/L